Bellevue Group »

AgomAb Therapeutics NV shares owned by Bellevue Group

Quarter-by-quarter ownership of AgomAb Therapeutics NV (AGMB) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Bellevue Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $525k 50k 10.49

More positions owned by Bellevue Group

Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Regeneron Pharmaceuticals (REGN)
Scholar Rock Hldg Corp (SRRK)
Gilead Sciences (GILD)
Revolution Medicines (RVMD)
Ionis Pharmaceuticals (IONS)
Intuitive Surgical Com New (ISRG)
Miragen Therapeutics (VRDN)
Krystal Biotech (KRYS)
Crinetics Pharmaceuticals In (CRNX)
Abbott Laboratories (ABT)
Nuvalent Inc-a (NUVL)
Amgen (AMGN)
Boston Scientific Corporation (BSX)

View all positions for Bellevue Group

Top funds holding AgomAb Therapeutics NV

EQT Fund Management S.a r.l.
Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
FMR
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
Siren
LMR Partners
Seven Grand Managers

View all funds holding AgomAb Therapeutics NV